rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2001-1-26
|
pubmed:abstractText |
The purpose of this study was to evaluate whether low molecular weight heparin (LMWH) could be equal or more effective than conventional oral anticoagulants (OAs) in the long-term treatment of deep venous thrombosis (DVT).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0741-5214
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
77-90
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11137927-Acenocoumarol,
pubmed-meshheading:11137927-Administration, Oral,
pubmed-meshheading:11137927-Adolescent,
pubmed-meshheading:11137927-Adult,
pubmed-meshheading:11137927-Aged,
pubmed-meshheading:11137927-Aged, 80 and over,
pubmed-meshheading:11137927-Anticoagulants,
pubmed-meshheading:11137927-Blood Coagulation Tests,
pubmed-meshheading:11137927-Female,
pubmed-meshheading:11137927-Hemorrhage,
pubmed-meshheading:11137927-Humans,
pubmed-meshheading:11137927-Injections, Subcutaneous,
pubmed-meshheading:11137927-Long-Term Care,
pubmed-meshheading:11137927-Male,
pubmed-meshheading:11137927-Middle Aged,
pubmed-meshheading:11137927-Nadroparin,
pubmed-meshheading:11137927-Survival Rate,
pubmed-meshheading:11137927-Thrombophlebitis,
pubmed-meshheading:11137927-Treatment Outcome,
pubmed-meshheading:11137927-Ultrasonography, Doppler, Duplex
|
pubmed:year |
2001
|
pubmed:articleTitle |
Low molecular weight heparin versus oral anticoagulants in the long-term treatment of deep venous thrombosis.
|
pubmed:affiliation |
Unit of Vascular Surgery, Cardiovascular Institute, Hospital Virgen de la Salud, Toledo, Spain. aromero@cht.es
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|